Oracle to pay $23M to settle FCPA violations in 3 countries
By 
Aaron Nicodemus2022-09-27T18:06:00
Technology giant Oracle Corp. will pay more than $23 million to settle allegations laid by the Securities and Exchange Commission (SEC) it violated the Foreign Corrupt Practices Act (FCPA) when its subsidiaries in India, Turkey, and the United Arab Emirates (UAE) bribed foreign officials for business.
The SEC said Tuesday that Oracle subsidiaries in Turkey and the UAE also used slush funds to pay foreign officials to attend international technology conferences, in some cases paying for family to accompany them or for side trips to California.
Without admitting or denying the agency’s allegations, Oracle agreed to cease and desist from further violations of the anti-bribery, books and records, and internal accounting control provisions of the FCPA. Oracle will pay approximately $8 million in disgorgement and a $15 million penalty.
Related articles
-
News BriefFlutter Entertainment to pay $4M for legacy FCPA violations
Ireland-based gaming and sports betting company Flutter Entertainment will pay a $4 million fine to resolve SEC charges payments made to Russian consultants by a company it acquired violated the Foreign Corrupt Practices Act.
-
ArticleSEC order against recidivist Oracle skirts the issue
The most notable and relevant details in settlement agreements concerning regulatory compliance violations are often what is not stated. The SEC’s cease-and-desist order against Oracle over violations of the Foreign Corrupt Practices Act is no exception.
-
ArticleBrazil airline Gol settles FCPA bribery charges for $41M
Brazilian airline Gol agreed to pay $41 million as part of reduced settlements addressing bribery investigations conducted by authorities in the United States and Brazil.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”